George M. Milne Jr. - 18 May 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Reporting relationship: Director
Issuer ticker: AUPH
Reported as of: 18 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 May 2023, 17:16:50 UTC
Prior SEC filing: 20 Mar 2023
Next SEC filing: 12 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ George M. Milne, Jr., Ph.D.

Key filing fact

George M. Milne Jr. filed Form 4 for Aurinia Pharmaceuticals Inc. (AUPH) on 23 May 2023.

Key facts

This page summarizes George M. Milne Jr.'s Form 4 filing for Aurinia Pharmaceuticals Inc. (AUPH).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 May 2023, 17:16.

Change

Previous filing in this sequence was filed on 20 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AUPH transaction

Common Stock

Options Exercise

Transaction value
Shares: +8,733
Change %: +12%
Price
Shares after: 78,733
Date: 18 May 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AUPH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -8,733
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 18 May 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,733
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .